Design, Synthesis and Development of Anticancer Drugs Targeting the Tumor Microenvironment
A Special Issue of International Journal of Molecular Sciences (ISSN 1422-0067) belonging to the section "Molecular Oncology".
Deadline for manuscript submissions: 30 November 2026 | Viewed by 760
Editor
Special Issue Information
Dear Colleagues,
Malignant tumors (cancer) have long been the leading cause of death in Japan and are also among the primary causes of mortality in other developed countries. Consequently, there is a persistent and growing need for excellent cancer treatments. In recent years, the development of anticancer drugs has increased significantly, with a large proportion of new therapeutic development focused on oncology.
Cancer is not composed solely of tumor cells; it develops through complex interactions with fibroblasts (cancer-associated fibroblast—CAF), endothelial cells (tumor endothelial cells—TECs), and immune cells (tumor-associated macrophage—TAMs). Therefore, it is difficult to eradicate cancer with drugs that target only tumor cells. There is a strong need for drugs that modulate the tumor microenvironment, including angiogenic inhibitors, anti-metastatic agents, hypoxic cytotoxins, and immunostimulants, as well as agents that enhance physicochemical therapies, such as radiosensitizers and ultrasound sensitizers.
Furthermore, in vivo models that accurately reproduce the tumor microenvironment are essential for screening these therapies. Chicken eggs offer an ideal alternative animal model, enabling the simple and rapid creation of a large number of tumor-bearing models.
This Special Issue welcomes a broad range of research and development focused on anticancer drugs that target the tumor microenvironment.
Prof. Dr. Yoshihiro Uto
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anticancer drugs
- tumor microenvironment
- in vivo model
- cancer-associated fibroblast
- tumor-associated macrophage
- tumor hypoxia
- tumor endothelial cells
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
